Clinical study on the effect of Amritadi Ghrita internally both for Shodhana[panchakarma] and Shamana[medication] in the dose of 30ml along with Nalpamaradi taila as an external application in patients of Plaque psoriasis with age between 18 to 60 years for a period of 30 days

A Controlled Clinical Study To Evaluate The Efficacy of Amritadi Ghrita as Shodhananga and Shamananga Snehapana in The Managemnet of Ekakushta - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102050

Enrollment

Registered

2026-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L408- Other psoriasis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects exhibiting the classical lakshanas of Ekakushta as described in Ayurvedic texts. Individuals presenting with clinical signs and symptoms of Plaque Psoriasis. Participants of irrespective gender any religion, occupation and economic status within the age group of 18 to 60 years. Chronicity of the disease should be less than 10 years. Subjects assessed and found fit for Virechana (therapeutic purgation). Both newly diagnosed (fresh) and previously treated cases of psoriasis will be considered for inclusion. Subjects who are willing to sign consent form voluntarily.

Exclusion criteria

Exclusion criteria: Subjects with co-morbid conditions such as Diabetes Mellitus, Hypertension, Cardiac disorders, Rheumatoid Arthritis and Systemic Lupus Erythematosus. Cases of Psoriatic Arthritis. Individuals in whom Snehapana and Virechana Karma are contraindicated. Pregnant and lactating women. Subjects diagnosed with skin disorders other than Ekakushta. Other types of psoriasis such as Guttate, Erythrodermic, or Pustular psoriasis.

Design outcomes

Primary

Measure	Time frame
Significant improvement noticed in reduction in signs and symptoms based on Psoriasis Area and Severity Index (PASI Scale)Timepoint: Before Treatment 0th day, After Virechana Karma, After 15 days of Shamananga Snehapana, Follow up on 45th day	—

Secondary

Measure	Time frame
Significant improvement noticed in the Quality of life (DLQI score) of patient & reduction in signs & symptoms of Ekakushta.Timepoint: Before Treatment 0th day, After Virechana Karma, After 15 days of Shamananga Snehapana, Follow up on 45th day	—

Countries

India

Contacts

Public ContactDr Shreekanth Gowda K C

Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Bangalore

drsharmamysr@gmail.com9964022654

Outcome results